RayzeBio Announces $173 Million Investment to Expand Radiopharmaceutical Manufacturing in Indiana
核心洞察
RayzeBio (搜索), a Bristol Myers Squibb (搜索) company, plans to invest more than $173 million to expand its radiopharmaceutical manufacturing operations in central Indiana.
The company will build a new 450,000-square-foot facility at Anson Industrial Park in Boone County, with construction expected to begin this year.
The expansion will create up to 100 new high-wage jobs at Indianapolis and Whitestown locations by the end of 2029, with average annual wages exceeding $130,000.
RayzeBio (搜索), Inc., a Bristol Myers Squibb (搜索) Company, announced plans to significantly expand its life sciences footprint in Indiana, investing more than $173 million in its central Indiana operations to advance the production of next-generation radiopharmaceutical therapies (RPTs). The announcement, made by Indiana Governor Mike Braun, further solidifies the state's reputation as the Radiopharmaceutical Capital of the World.
The company will establish a new, approximately 450,000-square-foot, state-of-the-art facility at the Anson Industrial Park in Boone County, with construction expected to begin this year. The expansion will grow RayzeBio (搜索)'s capacity to produce radiopharmaceutical therapies, which use radioisotopes to target and deliver internal radiation to cancer cells while seeking to reduce risk to surrounding organs and healthy tissues, potentially delivering better outcomes for patients living with cancer.
Manufacturing Expansion and Job Creation
The new Whitestown facility will complement RayzeBio (搜索)'s existing 77,000-square-foot radiopharmaceutical supply and manufacturing operation on the northeast side of Indianapolis, which is built to support clinical and commercial supply across the United States and worldwide. The company plans to create up to 100 new, high-wage jobs at its Indianapolis and planned Whitestown locations by the end of 2029, hiring for advanced manufacturing roles at both facilities with average annual wages expected to exceed $130,000.
"As a state, we are investing in our life sciences sector like never before, with plans to invest $1 billion and create 100,000 new jobs over the next 10 years," said Governor Braun. "RayzeBio (搜索)'s expansion and planned job creation will contribute to this growth, advancing life-changing solutions used across the world while creating even more high-wage career opportunities that allow Hoosiers to thrive."
Advancing Actinium-Based Radiopharmaceutical Therapies
California-based RayzeBio (搜索) was established in 2020 with the mission to advance cancer treatment and transform people's lives. The company, which was acquired by Bristol Myers Squibb (搜索) in 2024, is focused on advancing actinium-based RPTs and a pipeline of investigational drug development programs with the potential to be first-in-class and best-in-class. Current programs are aimed at addressing several types of solid tumors, including gastroenteropancreatic neuroendocrine tumors (搜索) (GEP-NET), liver and prostate cancers.
"Indiana is an important part of our strategy to build the infrastructure needed to advance the next generation of radiopharmaceutical therapies," said Ben Hickey, president of RayzeBio (搜索). "This investment expands our manufacturing capabilities, creates high-quality jobs, and strengthens our ability to deliver innovation for patients. We're proud to grow our presence in Indiana and contribute to the state's emergence as a leading hub for life sciences manufacturing."
Regional and Community Impact
The investment has drawn support from regional economic development leaders. "This project marks an important step in shaping Boone County's future as a hub for life sciences and advanced innovation," said Andrea Kern, CEO of the Boone County Economic Development Corporation. "The investment from Bristol Myers Squibb (搜索) through RayzeBio (搜索) will create high-quality jobs while reinforcing Central Indiana's position as a place that can move ideas from research through manufacturing and delivery into real-world impact, with Boone County playing a key role in advancing that work."
Eric Bischoff, Chief of Product Development and Operations at RayzeBio (搜索), added: "This new facility represents a meaningful investment in both patients and the Boone County community. By expanding our presence here, we're strengthening our ability to deliver innovative medicines for patients while creating high-quality jobs and advancing scientific capabilities in the region."
The expansion aligns with Indiana's broader strategic goal to invest $1 billion in the life sciences sector and create 100,000 jobs over the next decade, positioning the state as a leading hub for radiopharmaceutical manufacturing and innovation.